<DOC>
	<DOCNO>NCT00137787</DOCNO>
	<brief_summary>The aim study investigate whether intravenous ciprofloxacin effective cefepime initial treatment febrile neutropenia develop patient hematologic disease .</brief_summary>
	<brief_title>Comparing Ciprofloxacin ( CPFX ) With Cefepime ( CFPM ) Febrile Neutropenic Patients With Hematologic Diseases</brief_title>
	<detailed_description>Infectious complication neutropenic period major cause morbidity mortality especially patient hematological disease , prompt initiation antibiotic therapy warrant develop febrile neutropenia . As initial therapeutic agent , beta-lactam antibiotic , i.e. , third- fourth-generation cephalosporin carbapenems use frequently strong broad-spectrum action . However , condition , development resistance mediate beta-lactamase concern , need alternative non-beta-lactam antibiotic indication . Ciprofloxacin potent agent cover wide range strain include Pseudomonas aeruginosa , expect potential candidate . We therefore planned prospective randomize controlled trial design compare intravenous ciprofloxacin cefepime febrile neutropenic patient .</detailed_description>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Cefepime</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<criteria>Hematologic disease Ages 15 79 year Axillary temperature 38.0 C great one occasion 37.5 37.9 C last 1 hour Absolute neutrophil count le 500/microL TBil level le 2.0 time upper limit normal Cre level le 1.5 time upper limit normal Written inform consent Past history allergic reaction study drug Positive HIV antibody Pregnant lactate woman Family history auditory disturbance Having receive systemic antibacterial therapy within 14 day Receiving systemic antifungal antiviral therapy except fluconazole acyclovir case undergo transplantation No recovery neutrophil count 1,000/microL high previous febrile episode On treatment ketoprofen On treatment sodium valproate Septic shock</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>febrile neutropenia</keyword>
	<keyword>hematologic disease</keyword>
</DOC>